SOLARA ACTIVE PHARMA SCIENCES LTD

Overview

SOLARA ACTIVE PHARMA SCIENCES LTD is an active pharmaceutical ingredient (API) supplier with 95 active FDA Type II Drug Master Files, covering ACITRETIN; ACYCLOVIR SODIUM; ALBENDAZOLE; APREPITANT; ARTEMETHER; ARTESUNATE.

API / Drug Master Files

SOLARA ACTIVE PHARMA SCIENCES LTD holds 95 active (102 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SODIUM ZIRCONIUM CYCLOSILICATEActive2023-03-31
• ATRACURIUM BESYLATE USPActive2023-03-31
• NAPROXEN USPActive2023-03-31
• ROTIGOTINE USPActive2022-12-30
• NAPROXEN SODIUM USPActive2022-12-30
• LANTHANUM CARBONATE OCTAHYDRATEActive2022-03-30
• LANTHANUM CARBONATE TETRAHYDRATEActive2022-03-30
• IBUPROFEN LYSINEActive2022-03-29
• IBUPROFEN ARGININEActive2022-03-24
• BRIVARACETAMActive2021-09-30
• MYCOPHENOLATE SODIUM USPActive2021-03-31
• SAFINAMIDE MESYLATEActive2021-03-31
• MESALAMINE USPActive2021-03-30
• BUSPIRONE HYDROCHLORIDE USPActive2020-12-31
• ERYTHROMYCIN ETHYLSUCCINATE USPActive2020-12-31

Showing 15 of 102 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SOLARA ACTIVE PHARMA SCIENCES LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.